Mesenchymal stem cell therapy: A promising cell-based therapy for treatment of myocardial infarction

2017 ◽  
Vol 19 (12) ◽  
pp. e2995 ◽  
Author(s):  
Ayman El-Sayed Shafei ◽  
Mahmoud Ahmed Ali ◽  
Hazem G. Ghanem ◽  
Ahmed I. Shehata ◽  
Ahmed A. Abdelgawad ◽  
...  
Keyword(s):  
Myocardial Infarction ◽  
Stem Cell ◽  
Mesenchymal Stem Cell ◽  
Cell Therapy ◽  
Stem Cell Therapy ◽  
Mesenchymal Stem Cell Therapy ◽  
Cell Based Therapy

scholarly journals Therapeutic effect of mesenchymal stem cell therapy in the LVEF, LVEDV, and LVESV after myocardial infarction

2021 ◽  
Vol 122 (11) ◽  
pp. 785-792
Author(s):  
M. M. Rabiei ◽  
K. S. Khoramgah ◽  
I. A. Darazam ◽  
S. Vafaei-Nezhad ◽  
S. Dargahi ◽  
...  
Keyword(s):  
Myocardial Infarction ◽  
Stem Cell ◽  
Mesenchymal Stem Cell ◽  
Cell Therapy ◽  
Therapeutic Effect ◽  
Stem Cell Therapy ◽  
Mesenchymal Stem Cell Therapy

Mesenchymal stem cell therapy for human old myocardial infarction

2008 ◽  
Vol 44 (4) ◽  
pp. 711
Author(s):  
Mandana Mohyeddin Bonab ◽  
Mohamad R. Mohamadhassani ◽  
Hassan Emami Razavi ◽  
Mehdi Sanatkarfar ◽  
Behrouz Nikbin
Keyword(s):  
Myocardial Infarction ◽  
Stem Cell ◽  
Mesenchymal Stem Cell ◽  
Cell Therapy ◽  
Stem Cell Therapy ◽  
Mesenchymal Stem Cell Therapy ◽  
Old Myocardial Infarction

scholarly journals Precision regenerative medicine

2021 ◽  
Vol 12 (1) ◽  
Author(s):  
Amy L. Lightner ◽  
Timothy Chan
Keyword(s):  
Stem Cell ◽  
Regenerative Medicine ◽  
Mesenchymal Stem Cell ◽  
Cell Therapy ◽  
Stem Cell Therapy ◽  
Individualized Medicine ◽  
Main Body ◽  
Mesenchymal Stem Cell Therapy ◽  
Disease States ◽  
Cell Based Therapy

Abstract Background Precision or individualized medicine is increasingly pervasive across medical and surgical disciplines. However, the concept has not been introduced in regenerative medicine. Main body Targeted and engineered cellular and acellular therapy, specific to individuals or disease states, could significantly improve the efficacy of these autologous therapies. Currently, generic mesenchymal stem cell therapy is being widely used across multiple pathologies, some of which may not respond well to mesenchymal stem cell therapy. Engineered cell therapy may be a way to address this generic one-size-fits-all approach. Conclusions The future of regenerative medicine lies in the concept of precision cell-based therapy.

Sign in / Sign up

Export Citation Format

Share Document